Deng Y, Zhou M, Wang J, Yao J, Yu J, Liu W, et al
Translational identification of transcriptional signatures of major depression and antidepressant response
2 Differential processing of proglucagon in the intestinal epithelial endocrine L-cells produces the 30-amino acid peptide hormone GLP-1
Please note that injectable weight loss medications are not covered by Medicare for obesity alone
These medications belong to a class of treatments known as GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists, both of which help patients achieve gradual, sustainable weight loss while improving overall metabolic health
In fact, pairing them may provide differing benefits to better assist your overall health